Article info
PDFOriginal research
Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Correspondence to Mrs Eline M Bunnik, Medical Ethics and Philosophy of Medicine, Erasmus MC, Rotterdam 3015 GE, Netherlands; e.bunnik{at}erasmusmc.nl
Citation
Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
Publication history
- Received July 3, 2019
- Revised September 2, 2019
- Accepted September 9, 2019
- First published September 16, 2019.
Online issue publication
February 21, 2020
Article Versions
- Previous version (21 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Why NIPT should be publicly funded
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis
- ‘Is it better not to know certain things?’: views of women who have undergone non-invasive prenatal testing on its possible future applications
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Preserving women’s reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany
- Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis